Task: Answer the multiple-choice question.
Question: Which drug exhibits a -11.983% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
[a] CCOc1ccc(-c2ccc(/C=C3/C(=N)N4C=CSC4=NC3=O)o2)c([N+](=O)[O-])c1
[b] O=C(/C=C/c1ccccc1)NCCSCc1ccc(Cl)cc1
[c] Clc1ccc(Cn2ncc3c(NCc4ccco4)ncnc32)c(Cl)c1
Answer: c. Clc1ccc(Cn2ncc3c(NCc4ccco4)ncnc32)c(Cl)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Clc1ccc(Cn2ncc3c(NCc4ccco4)ncnc32)c(Cl)c1
Clc1ccc(Cn2ncc3c(NCc4ccco4)ncnc32)c(Cl)c1
1-[(2,4-dichlorophenyl)methyl]-N-(furan-2-ylmethyl)pyrazolo[3,4-d]pyrimidin-4-amine